Convertible Bond Facility

Paris, France and Camberley, UK – 23 April 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that it has entered into a Convertible Bonds with Warrants Funding Programme (“Agreement”), for up to €5.0 million (net of expenses) with Park Partners GP and Negma Group LTD (“Park Partners”, “Negma”, together the “Investor”).